COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.

Authors :: Conforti C
Giuffrida R
Dianzani C
Di Meo N
Zalaudek I
Source :: Dermatologic therapy [Dermatol Ther] 2020 Jul; Vol. 33 (4), pp. e13298. Date of Electronic Publication: 2020 Mar 22.
Publication Year :: 2020

Subjects :: COVID-19
Coronavirus Infections epidemiology
Humans
Immunosuppressive Agents adverse effects
Pandemics
Pneumonia, Viral epidemiology
Psoriasis complications
Risk Factors
Coronavirus Infections complications
Immunosuppressive Agents administration & dosage
Pneumonia, Viral complications
Psoriasis drug therapy

Full Text Access

Tools